share_log

Ligand Pharmaceuticals(LGND.US) Director Sells US$140.65K in Common Stocks

moomoo News ·  Mar 7 14:09

$Ligand Pharmaceuticals (LGND.US)$ Director Sabba Stephen L sold 1,893 shares of Common Stocks on Mar 5, 2024 at an average price of $74.3 for a total value of $140.65K.

1709838542730124187.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment